These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20198983)

  • 21. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
    Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
    Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
    Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of female sex hormone receptors in human middle-ear cholesteatomas.
    Raynov AM; Choung YH; Moon SK; Park K
    J Laryngol Otol; 2005 Dec; 119(12):941-5. PubMed ID: 16354354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
    Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
    Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
    Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
    Liu J; Lin G; Huang J; Jiang Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of gene expression profiles in cholesteatoma using oligonucleotide microarray.
    Kwon KH; Kim SJ; Kim HJ; Jung HH
    Acta Otolaryngol; 2006 Jul; 126(7):691-7. PubMed ID: 16803706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expressions of TRPVs in the cholesteatoma epithelium.
    Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
    Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hexosaminidase as a new potential marker for middle ear cholesteatoma.
    Olszewska E; Borzym-Kluczyk M; Olszewski S; Rogowski M; Zwierz K
    Clin Biochem; 2006 Nov; 39(11):1088-90. PubMed ID: 17052699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical investigations of cathepsin D activity in the structures of cholesteatoma.
    Chodynicki S; Chyczewski L; Olszewska E
    Med Sci Monit; 2002 May; 8(5):BR184-6. PubMed ID: 12011767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
    Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear.
    Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Kakihana M; Shimano K; Terada N; Sakagami M
    Auris Nasus Larynx; 2004 Mar; 31(1):3-9. PubMed ID: 15041047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma.
    Yoshikawa M; Kojima H; Wada K; Tsukidate T; Okada N; Saito H; Moriyama H
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):734-42. PubMed ID: 16847181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma.
    Shiwa M; Kojima H; Moriyama H
    J Laryngol Otol; 1998 Aug; 112(8):750-4. PubMed ID: 9850316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.